[1] |
Espinha G, Osaki JH, Costa ET, et al. Inhibition of the RhoA GTPase activity increases sensitivity of melanoma cells to UV radiation effects[J]. Oxid Med Cell Longev, 2016, 2016: 2696952. DOI: 10.1155/2016/2696952.
|
[2] |
Aspenström P. Atypical Rho GTPases RhoD and Rif integrate cytoskeletal dynamics and membrane trafficking[J]. Biol Chem, 2014, 395(5): 477⁃484. DOI: 10.1515/hsz⁃2013⁃0296.
|
[3] |
Orgaz JL, Herraiz C, Sanz⁃Moreno V. Rho GTPases modulate malignant transformation of tumor cells[J]. Small GTPases, 2014, 5: e29019. DOI: 10.4161/sgtp.29019.
|
[4] |
Rath N, Olson MF. Rho⁃associated kinases in tumorigenesis: re⁃considering ROCK inhibition for cancer therapy[J]. EMBO Rep, 2012, 13(10): 900⁃908. DOI: 10.1038/embor.2012.127.
|
[5] |
Jaffe AB, Hall A. Rho GTPases: biochemistry and biology[J]. Annu Rev Cell Dev Biol, 2005, 21: 247⁃269. DOI: 10.1146/annurev.cellbio.21.020604.150721.
|
[6] |
Sahai E, Marshall CJ. RHO⁃GTPases and cancer[J]. Nat Rev Cancer, 2002, 2(2): 133⁃142. DOI: 10.1038/nrc725.
|
[7] |
Kamai T, Yamanishi T, Shirataki H, et al. Over of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer[J]. Clin Cancer Res, 2004, 10(14): 4799⁃4805. DOI: 10.1158/1078⁃0432.CCR⁃0436⁃03.
|
[8] |
Fritz G, Brachetti C, Bahlmann F, et al. Rho GTPases in human breast tumours: and mutation analyses and correlation with clinical parameters[J]. Br J Cancer, 2002, 87(6): 635⁃644. DOI: 10.1038/sj.bjc.6600510.
|
[9] |
van Golen KL, Wu ZF, Qiao XT, et al. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype[J]. Cancer Res, 2000, 60(20): 5832⁃5838.
|
[10] |
Wang HB, Liu XP, Liang J, et al. Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters[J]. Clin Chem Lab Med, 2009, 47(7): 811⁃817. DOI: 10.1515/CCLM.2009.186.
|
[11] |
Wang J, Rao Q, Wang M, et al. Over of Rac1 in leukemia patients and its role in leukemia cell migration and growth[J]. Biochem Biophys Res Commun, 2009, 386(4): 769⁃774. DOI: 10.1016/j.bbrc.2009.06.125.
|
[12] |
Liu Y, Wang Y, Zhang Y, et al. Abnormal of p120⁃catenin, E⁃cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer[J]. Lung Cancer, 2009, 63(3): 375⁃382. DOI: 10.1016/j.lungcan.2008. 12.012.
|
[13] |
Adnane J, Muro⁃Cacho C, Mathews L, et al. Suppression of rho B in invasive carcinoma from head and neck cancer patients[J]. Clin Cancer Res, 2002, 8(7): 2225⁃2232.
|
[14] |
Mazieres J, Antonia T, Daste G, et al. Loss of RhoB in human lung cancer progression[J]. Clin Cancer Res, 2004, 10(8): 2742⁃2750.
|
[15] |
Tsubakimoto K, Matsumoto K, Abe H, et al. Small GTPase RhoD suppresses cell migration and cytokinesis[J]. Oncogene, 1999, 18(15): 2431⁃2440. DOI: 10.1038/sj.onc.1202604.
|
[16] |
Murphy C, Saffrich R, Olivo⁃Marin JC, et al. Dual function of rhoD in vesicular movement and cell motility[J]. Eur J Cell Biol, 2001, 80(6): 391⁃398. DOI: 10.1078/0171⁃9335⁃00173.
|
[17] |
Murphy C, Saffrich R, Grummt M, et al. Endosome dynamics regulated by a Rho protein[J]. Nature, 1996, 384(6608): 427⁃432. DOI: 10.1038/384427a0.
|
[18] |
Gad AK, Nehru V, Ruusala A, et al. RhoD regulates cytoskeletal dynamics via the actin nucleation⁃promoting factor WASp homologue associated with actin Golgi membranes and microtubules[J]. Mol Biol Cell, 2012, 23(24): 4807⁃4819. DOI: 10.1091/mbc.E12⁃07⁃0555.
|
[19] |
Aspenström P, Fransson A, Saras J. Rho GTPases have diverse effects on the organization of the actin filament system[J]. Biochem J, 2004, 377(Pt 2): 327⁃337. DOI: 10.1042/BJ20031041.
|
[20] |
Koizumi K, Takano K, Kaneyasu A, et al. RhoD activated by fibroblast growth factor induces cytoneme⁃like cellular protrusions through mDia3C[J]. Mol Biol Cell, 2012, 23(23): 4647⁃4661. DOI: 10.1091/mbc.E12⁃04⁃0315.
|